Fig. 4: Phenotypes of SIRPα+ cells and levels of SIRPα expression. | Nature Communications

Fig. 4: Phenotypes of SIRPα+ cells and levels of SIRPα expression.

From: Vaccination with CD47 deficient tumor cells elicits an antitumor immune response in mice

Fig. 4

Spleen cells harvested 24 h after vaccination with 2.5 × 106 irradiated WT or CD47KO B16F0 cells were analyzed for SIRPα expression on various cell populations by flow cytometry. a Representative flow cytometry profiles showing the ratio of SIRPα+ cells (left), CD11b and CD11c expression gated SIRPα+ cells (middle), and levels of SIRPα expression on gated CD11b+CD11c+ DCs (open histogram), CD11bCD11c+ DCs (gray shaded histogram) and CD11b+CD11c myeloid cells (black shaded histogram; right). b MFI of SIRPα expression on the indicated cell populations. **p < 0.01; ***p < 0.005 (one-way ANOVA). c Percentages of total SIRPα+ cells. d Percentages of SIRPα+CD11b+CD11c myeloid cells. e Percentages of total SIRPα+CD11c+, SIRPα+CD11c+CD11b+, and SIRPα+CD11c+CD11b DC subsets. Results are presented as mean ± SEM (n = 4 per group). *p < 0.05; **p < 0.01; ***p < 0.005; ns, not significant (unpaired t-test). Source data are provided as a Source Data file.

Back to article page